nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—ABCB1—peripheral nervous system neoplasm	0.227	1	CbGaD
Amiodarone—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0554	0.101	CbGbCtD
Amiodarone—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0473	0.0865	CbGbCtD
Amiodarone—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0407	0.0744	CbGbCtD
Amiodarone—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0379	0.0692	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0379	0.0692	CbGbCtD
Amiodarone—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0284	0.0519	CbGbCtD
Amiodarone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0273	0.0499	CbGbCtD
Amiodarone—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0227	0.0416	CbGbCtD
Amiodarone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0199	0.0363	CbGbCtD
Amiodarone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0199	0.0363	CbGbCtD
Amiodarone—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.019	0.0348	CbGbCtD
Amiodarone—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0182	0.0332	CbGbCtD
Amiodarone—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0174	0.0318	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0174	0.0318	CbGbCtD
Amiodarone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0138	0.0252	CbGbCtD
Amiodarone—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.013	0.0238	CbGbCtD
Amiodarone—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0119	0.0218	CbGbCtD
Amiodarone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0119	0.0218	CbGbCtD
Amiodarone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0115	0.021	CbGbCtD
Amiodarone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0111	0.0202	CbGbCtD
Amiodarone—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00889	0.0163	CbGbCtD
Amiodarone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00848	0.0155	CbGbCtD
Amiodarone—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00815	0.0149	CbGbCtD
Amiodarone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00791	0.0145	CbGbCtD
Amiodarone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00778	0.0142	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0053	0.00969	CbGbCtD
Amiodarone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00508	0.00929	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.005	0.00913	CbGbCtD
Amiodarone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00466	0.00852	CbGbCtD
Amiodarone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00318	0.00581	CbGbCtD
Amiodarone—Oxybuprocaine—BCHE—peripheral nervous system neoplasm	0.00164	0.457	CrCbGaD
Amiodarone—Cinchocaine—BCHE—peripheral nervous system neoplasm	0.00145	0.406	CrCbGaD
Amiodarone—Dronedarone—ABCB1—peripheral nervous system neoplasm	0.00049	0.137	CrCbGaD
Amiodarone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000505	CcSEcCtD
Amiodarone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000108	0.000505	CcSEcCtD
Amiodarone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000108	0.000505	CcSEcCtD
Amiodarone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000108	0.000505	CcSEcCtD
Amiodarone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000108	0.000503	CcSEcCtD
Amiodarone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000503	CcSEcCtD
Amiodarone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000108	0.000502	CcSEcCtD
Amiodarone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000108	0.000502	CcSEcCtD
Amiodarone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000501	CcSEcCtD
Amiodarone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000107	0.000501	CcSEcCtD
Amiodarone—Pain—Vincristine—peripheral nervous system neoplasm	0.000107	0.000501	CcSEcCtD
Amiodarone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000501	CcSEcCtD
Amiodarone—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000107	0.0005	CcSEcCtD
Amiodarone—Rash—Melphalan—peripheral nervous system neoplasm	0.000107	0.000499	CcSEcCtD
Amiodarone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000107	0.000499	CcSEcCtD
Amiodarone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000497	CcSEcCtD
Amiodarone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000494	CcSEcCtD
Amiodarone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000105	0.000489	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000487	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000487	CcSEcCtD
Amiodarone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000104	0.000484	CcSEcCtD
Amiodarone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000104	0.000483	CcSEcCtD
Amiodarone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.000483	CcSEcCtD
Amiodarone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000481	CcSEcCtD
Amiodarone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000481	CcSEcCtD
Amiodarone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000103	0.00048	CcSEcCtD
Amiodarone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000103	0.000479	CcSEcCtD
Amiodarone—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000103	0.000478	CcSEcCtD
Amiodarone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000477	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000477	CcSEcCtD
Amiodarone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000102	0.000476	CcSEcCtD
Amiodarone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000102	0.000476	CcSEcCtD
Amiodarone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000476	CcSEcCtD
Amiodarone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000102	0.000474	CcSEcCtD
Amiodarone—Infection—Etoposide—peripheral nervous system neoplasm	0.000101	0.000471	CcSEcCtD
Amiodarone—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000471	CcSEcCtD
Amiodarone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000101	0.00047	CcSEcCtD
Amiodarone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000101	0.00047	CcSEcCtD
Amiodarone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	9.97e-05	0.000465	CcSEcCtD
Amiodarone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	9.96e-05	0.000465	CcSEcCtD
Amiodarone—Tachycardia—Etoposide—peripheral nervous system neoplasm	9.93e-05	0.000463	CcSEcCtD
Amiodarone—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	9.93e-05	0.000463	CcSEcCtD
Amiodarone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	9.93e-05	0.000463	CcSEcCtD
Amiodarone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	9.93e-05	0.000463	CcSEcCtD
Amiodarone—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.000462	CcSEcCtD
Amiodarone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	9.9e-05	0.000462	CcSEcCtD
Amiodarone—Skin disorder—Etoposide—peripheral nervous system neoplasm	9.88e-05	0.000461	CcSEcCtD
Amiodarone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	9.83e-05	0.000459	CcSEcCtD
Amiodarone—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000459	CcSEcCtD
Amiodarone—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	9.77e-05	0.000456	CcSEcCtD
Amiodarone—Anorexia—Etoposide—peripheral nervous system neoplasm	9.7e-05	0.000452	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000451	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000451	CcSEcCtD
Amiodarone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	9.65e-05	0.00045	CcSEcCtD
Amiodarone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	9.62e-05	0.000449	CcSEcCtD
Amiodarone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	9.6e-05	0.000448	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	9.59e-05	0.000447	CcSEcCtD
Amiodarone—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000444	CcSEcCtD
Amiodarone—Hypotension—Etoposide—peripheral nervous system neoplasm	9.5e-05	0.000443	CcSEcCtD
Amiodarone—Pain—Cisplatin—peripheral nervous system neoplasm	9.49e-05	0.000443	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	9.47e-05	0.000442	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	9.47e-05	0.000442	CcSEcCtD
Amiodarone—Neutropenia—Epirubicin—peripheral nervous system neoplasm	9.38e-05	0.000437	CcSEcCtD
Amiodarone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.35e-05	0.000436	CcSEcCtD
Amiodarone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.25e-05	0.000432	CcSEcCtD
Amiodarone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.22e-05	0.00043	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	9.19e-05	0.000428	CcSEcCtD
Amiodarone—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	9.15e-05	0.000427	CcSEcCtD
Amiodarone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	9.15e-05	0.000427	CcSEcCtD
Amiodarone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.13e-05	0.000426	CcSEcCtD
Amiodarone—Weight increased—Epirubicin—peripheral nervous system neoplasm	9.12e-05	0.000426	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000424	CcSEcCtD
Amiodarone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	9.07e-05	0.000423	CcSEcCtD
Amiodarone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	9.07e-05	0.000423	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.000422	CcSEcCtD
Amiodarone—Asthenia—Vincristine—peripheral nervous system neoplasm	9.01e-05	0.00042	CcSEcCtD
Amiodarone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000419	CcSEcCtD
Amiodarone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.94e-05	0.000417	CcSEcCtD
Amiodarone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.92e-05	0.000416	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000413	CcSEcCtD
Amiodarone—Rash—Dactinomycin—peripheral nervous system neoplasm	8.86e-05	0.000413	CcSEcCtD
Amiodarone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	8.84e-05	0.000412	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000411	CcSEcCtD
Amiodarone—Renal failure—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.00041	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	8.78e-05	0.00041	CcSEcCtD
Amiodarone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.78e-05	0.000409	CcSEcCtD
Amiodarone—Fatigue—Etoposide—peripheral nervous system neoplasm	8.77e-05	0.000409	CcSEcCtD
Amiodarone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.76e-05	0.000409	CcSEcCtD
Amiodarone—Jaundice—Epirubicin—peripheral nervous system neoplasm	8.71e-05	0.000406	CcSEcCtD
Amiodarone—Constipation—Etoposide—peripheral nervous system neoplasm	8.7e-05	0.000406	CcSEcCtD
Amiodarone—Pain—Etoposide—peripheral nervous system neoplasm	8.7e-05	0.000406	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000405	CcSEcCtD
Amiodarone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.62e-05	0.000402	CcSEcCtD
Amiodarone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.59e-05	0.000401	CcSEcCtD
Amiodarone—Sweating—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.0004	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	0.000395	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	8.44e-05	0.000394	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	8.39e-05	0.000392	CcSEcCtD
Amiodarone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.38e-05	0.000391	CcSEcCtD
Amiodarone—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.35e-05	0.000389	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	8.34e-05	0.000389	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.000388	CcSEcCtD
Amiodarone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.32e-05	0.000388	CcSEcCtD
Amiodarone—Dizziness—Vincristine—peripheral nervous system neoplasm	8.3e-05	0.000387	CcSEcCtD
Amiodarone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.28e-05	0.000386	CcSEcCtD
Amiodarone—Rash—Alitretinoin—peripheral nervous system neoplasm	8.22e-05	0.000383	CcSEcCtD
Amiodarone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.21e-05	0.000383	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000383	CcSEcCtD
Amiodarone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.18e-05	0.000382	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000381	CcSEcCtD
Amiodarone—Headache—Alitretinoin—peripheral nervous system neoplasm	8.16e-05	0.000381	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000379	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.11e-05	0.000378	CcSEcCtD
Amiodarone—Urticaria—Etoposide—peripheral nervous system neoplasm	8.08e-05	0.000377	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—peripheral nervous system neoplasm	8.06e-05	0.000376	CcSEcCtD
Amiodarone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.04e-05	0.000375	CcSEcCtD
Amiodarone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.04e-05	0.000375	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000374	CcSEcCtD
Amiodarone—Vomiting—Vincristine—peripheral nervous system neoplasm	7.98e-05	0.000372	CcSEcCtD
Amiodarone—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.97e-05	0.000372	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.00037	CcSEcCtD
Amiodarone—Rash—Vincristine—peripheral nervous system neoplasm	7.92e-05	0.000369	CcSEcCtD
Amiodarone—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.91e-05	0.000369	CcSEcCtD
Amiodarone—Headache—Vincristine—peripheral nervous system neoplasm	7.87e-05	0.000367	CcSEcCtD
Amiodarone—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.74e-05	0.000361	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000361	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	7.72e-05	0.00036	CcSEcCtD
Amiodarone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.6e-05	0.000354	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000354	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000353	CcSEcCtD
Amiodarone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.49e-05	0.00035	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000349	CcSEcCtD
Amiodarone—Nausea—Vincristine—peripheral nervous system neoplasm	7.46e-05	0.000348	CcSEcCtD
Amiodarone—Flushing—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000347	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000346	CcSEcCtD
Amiodarone—Asthenia—Etoposide—peripheral nervous system neoplasm	7.3e-05	0.00034	CcSEcCtD
Amiodarone—Pruritus—Etoposide—peripheral nervous system neoplasm	7.2e-05	0.000336	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.000334	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.16e-05	0.000334	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000331	CcSEcCtD
Amiodarone—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.06e-05	0.000329	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000328	CcSEcCtD
Amiodarone—Rash—Cisplatin—peripheral nervous system neoplasm	7e-05	0.000327	CcSEcCtD
Amiodarone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.99e-05	0.000326	CcSEcCtD
Amiodarone—Erythema—Epirubicin—peripheral nervous system neoplasm	6.99e-05	0.000326	CcSEcCtD
Amiodarone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.96e-05	0.000325	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000323	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000321	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000319	CcSEcCtD
Amiodarone—Back pain—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000315	CcSEcCtD
Amiodarone—Dizziness—Etoposide—peripheral nervous system neoplasm	6.73e-05	0.000314	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.63e-05	0.000309	CcSEcCtD
Amiodarone—Nausea—Cisplatin—peripheral nervous system neoplasm	6.59e-05	0.000308	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	6.58e-05	0.000307	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000306	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000302	CcSEcCtD
Amiodarone—Vomiting—Etoposide—peripheral nervous system neoplasm	6.47e-05	0.000302	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000302	CcSEcCtD
Amiodarone—Agitation—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000299	CcSEcCtD
Amiodarone—Rash—Etoposide—peripheral nervous system neoplasm	6.41e-05	0.000299	CcSEcCtD
Amiodarone—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.41e-05	0.000299	CcSEcCtD
Amiodarone—Headache—Etoposide—peripheral nervous system neoplasm	6.37e-05	0.000297	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000295	CcSEcCtD
Amiodarone—Malaise—Epirubicin—peripheral nervous system neoplasm	6.3e-05	0.000294	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000293	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000292	CcSEcCtD
Amiodarone—Cough—Epirubicin—peripheral nervous system neoplasm	6.1e-05	0.000284	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000284	CcSEcCtD
Amiodarone—Nausea—Etoposide—peripheral nervous system neoplasm	6.04e-05	0.000282	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.00028	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000277	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000276	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000274	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000272	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.000271	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000271	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000268	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000266	CcSEcCtD
Amiodarone—Oedema—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000266	CcSEcCtD
Amiodarone—Infection—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000264	CcSEcCtD
Amiodarone—Cough—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000263	CcSEcCtD
Amiodarone—Shock—Epirubicin—peripheral nervous system neoplasm	5.61e-05	0.000262	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.00026	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.56e-05	0.00026	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000258	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000257	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000256	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000254	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000254	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000251	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000249	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000248	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000246	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000246	CcSEcCtD
Amiodarone—Infection—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000244	CcSEcCtD
Amiodarone—Shock—Doxorubicin—peripheral nervous system neoplasm	5.19e-05	0.000242	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000241	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000241	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.00024	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000239	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.12e-05	0.000239	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000238	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000237	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000235	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000234	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000231	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.00023	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.00023	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.000229	CcSEcCtD
Amiodarone—Pain—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000227	CcSEcCtD
Amiodarone—Constipation—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000227	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000223	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000221	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000219	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000219	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000217	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000217	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000214	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000212	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000212	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000211	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.00021	CcSEcCtD
Amiodarone—Pain—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.00021	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.00021	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.00021	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000203	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000201	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000196	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000196	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000195	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000195	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.000191	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000188	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000182	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000181	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000177	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000176	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000174	CcSEcCtD
Amiodarone—EBP—Metabolism—NME1—peripheral nervous system neoplasm	3.68e-05	0.00491	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	3.63e-05	0.00485	CbGpPWpGaD
Amiodarone—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000169	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000168	CcSEcCtD
Amiodarone—Rash—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000168	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000168	CcSEcCtD
Amiodarone—Headache—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.000167	CcSEcCtD
Amiodarone—EBP—Metabolism—COX2—peripheral nervous system neoplasm	3.54e-05	0.00473	CbGpPWpGaD
Amiodarone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000163	CcSEcCtD
Amiodarone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.43e-05	0.00458	CbGpPWpGaD
Amiodarone—Nausea—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000158	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000156	CcSEcCtD
Amiodarone—Rash—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000155	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000155	CcSEcCtD
Amiodarone—Headache—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000154	CcSEcCtD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	3.2e-05	0.00427	CbGpPWpGaD
Amiodarone—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000146	CcSEcCtD
Amiodarone—KCNH2—Neuronal System—BCHE—peripheral nervous system neoplasm	3.1e-05	0.00415	CbGpPWpGaD
Amiodarone—ADRB1—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	2.99e-05	0.00399	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	2.85e-05	0.00381	CbGpPWpGaD
Amiodarone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.78e-05	0.00371	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.76e-05	0.00369	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—GNS—peripheral nervous system neoplasm	2.73e-05	0.00365	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	2.68e-05	0.00359	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—MET—peripheral nervous system neoplasm	2.68e-05	0.00358	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.65e-05	0.00354	CbGpPWpGaD
Amiodarone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.65e-05	0.00353	CbGpPWpGaD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	2.63e-05	0.00352	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—NME1—peripheral nervous system neoplasm	2.62e-05	0.0035	CbGpPWpGaD
Amiodarone—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	2.58e-05	0.00345	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—COX2—peripheral nervous system neoplasm	2.52e-05	0.00337	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—PTPN11—peripheral nervous system neoplasm	2.48e-05	0.00331	CbGpPWpGaD
Amiodarone—CYP2A6—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	2.41e-05	0.00322	CbGpPWpGaD
Amiodarone—EBP—Metabolism—ENO2—peripheral nervous system neoplasm	2.32e-05	0.00311	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	2.18e-05	0.00292	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.02e-05	0.0027	CbGpPWpGaD
Amiodarone—EBP—Metabolism—BCHE—peripheral nervous system neoplasm	1.96e-05	0.00262	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—ERBB2—peripheral nervous system neoplasm	1.96e-05	0.00262	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.95e-05	0.00261	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MET—peripheral nervous system neoplasm	1.91e-05	0.00255	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.89e-05	0.00253	CbGpPWpGaD
Amiodarone—EBP—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.87e-05	0.0025	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.86e-05	0.00248	CbGpPWpGaD
Amiodarone—EBP—Metabolism—TH—peripheral nervous system neoplasm	1.85e-05	0.00247	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.8e-05	0.0024	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.79e-05	0.00239	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—PTPN11—peripheral nervous system neoplasm	1.77e-05	0.00236	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.7e-05	0.00227	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.67e-05	0.00224	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.66e-05	0.00221	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ENO2—peripheral nervous system neoplasm	1.66e-05	0.00221	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.63e-05	0.00218	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.56e-05	0.00209	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.51e-05	0.00202	CbGpPWpGaD
Amiodarone—EBP—Metabolism—GNAS—peripheral nervous system neoplasm	1.51e-05	0.00201	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—NRAS—peripheral nervous system neoplasm	1.49e-05	0.00199	CbGpPWpGaD
Amiodarone—EBP—Metabolism—ABCB1—peripheral nervous system neoplasm	1.48e-05	0.00198	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.43e-05	0.00191	CbGpPWpGaD
Amiodarone—THRB—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.43e-05	0.00191	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.42e-05	0.00189	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.41e-05	0.00189	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—BCHE—peripheral nervous system neoplasm	1.4e-05	0.00187	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.4e-05	0.00187	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.36e-05	0.00182	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.33e-05	0.00178	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.33e-05	0.00178	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.32e-05	0.00176	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—TH—peripheral nervous system neoplasm	1.32e-05	0.00176	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.32e-05	0.00176	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.31e-05	0.00176	CbGpPWpGaD
Amiodarone—CACNA2D2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.3e-05	0.00174	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.29e-05	0.00172	CbGpPWpGaD
Amiodarone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.27e-05	0.0017	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.24e-05	0.00166	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.22e-05	0.00164	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.21e-05	0.00162	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.2e-05	0.0016	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.18e-05	0.00158	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.15e-05	0.00153	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.11e-05	0.00148	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.1e-05	0.00147	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.09e-05	0.00146	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—HRAS—peripheral nervous system neoplasm	1.09e-05	0.00146	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.09e-05	0.00145	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.07e-05	0.00144	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—GNAS—peripheral nervous system neoplasm	1.07e-05	0.00143	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.07e-05	0.00143	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.07e-05	0.00142	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.06e-05	0.00142	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.05e-05	0.00141	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.03e-05	0.00137	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1e-05	0.00134	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.96e-06	0.00133	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.91e-06	0.00132	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	9.54e-06	0.00128	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.54e-06	0.00128	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	9.15e-06	0.00122	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.02e-06	0.0012	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	8.81e-06	0.00118	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	8.75e-06	0.00117	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.51e-06	0.00114	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	8.39e-06	0.00112	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	8.38e-06	0.00112	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.37e-06	0.00112	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.27e-06	0.0011	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	8.07e-06	0.00108	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.03e-06	0.00107	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—HRAS—peripheral nervous system neoplasm	7.78e-06	0.00104	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.49e-06	0.001	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.38e-06	0.000986	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—HRAS—peripheral nervous system neoplasm	7.28e-06	0.000973	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.2e-06	0.000962	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.01e-06	0.000937	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	6.95e-06	0.000928	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—MYC—peripheral nervous system neoplasm	6.9e-06	0.000922	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—MYC—peripheral nervous system neoplasm	6.9e-06	0.000922	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	6.9e-06	0.000922	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.87e-06	0.000918	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—AKT1—peripheral nervous system neoplasm	6.87e-06	0.000917	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.79e-06	0.000907	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.73e-06	0.000899	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	6.61e-06	0.000884	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.57e-06	0.000878	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	6.52e-06	0.000871	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.37e-06	0.000851	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	6.37e-06	0.000851	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.35e-06	0.000848	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	6.25e-06	0.000835	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.13e-06	0.00082	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.13e-06	0.000819	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	6.04e-06	0.000807	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	6.02e-06	0.000804	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	5.98e-06	0.000798	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.86e-06	0.000783	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	5.78e-06	0.000773	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.75e-06	0.000768	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	5.73e-06	0.000766	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.59e-06	0.000747	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.57e-06	0.000744	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	5.51e-06	0.000737	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.48e-06	0.000733	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.43e-06	0.000725	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	5.33e-06	0.000713	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	5.3e-06	0.000708	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	5.21e-06	0.000696	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	5.11e-06	0.000683	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	4.99e-06	0.000667	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	4.92e-06	0.000658	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	4.91e-06	0.000656	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	4.89e-06	0.000653	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	4.86e-06	0.00065	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	4.8e-06	0.000642	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—AKT1—peripheral nervous system neoplasm	4.78e-06	0.000639	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—AKT1—peripheral nervous system neoplasm	4.78e-06	0.000639	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.78e-06	0.000638	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	4.7e-06	0.000628	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	4.66e-06	0.000623	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.66e-06	0.000623	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	4.59e-06	0.000614	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	4.53e-06	0.000605	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	4.49e-06	0.0006	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	4.48e-06	0.000598	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.44e-06	0.000593	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.4e-06	0.000588	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.37e-06	0.000584	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	4.28e-06	0.000572	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.27e-06	0.000571	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	4.21e-06	0.000563	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	4.18e-06	0.000559	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	4.16e-06	0.000555	CbGpPWpGaD
Amiodarone—EBP—Metabolism—AKT1—peripheral nervous system neoplasm	4.07e-06	0.000544	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.98e-06	0.000532	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	3.95e-06	0.000528	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.87e-06	0.000517	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.84e-06	0.000512	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.76e-06	0.000503	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	3.75e-06	0.000501	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	3.68e-06	0.000492	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	3.62e-06	0.000484	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.59e-06	0.000479	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	3.53e-06	0.000472	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.52e-06	0.00047	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	3.44e-06	0.000459	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.37e-06	0.000451	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.37e-06	0.00045	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	3.34e-06	0.000446	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	3.32e-06	0.000444	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.29e-06	0.00044	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	3.23e-06	0.000432	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.21e-06	0.000429	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.18e-06	0.000425	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	3.15e-06	0.000421	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	3.14e-06	0.000419	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.08e-06	0.000411	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	3.06e-06	0.000409	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.97e-06	0.000397	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.97e-06	0.000397	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.96e-06	0.000396	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	2.95e-06	0.000394	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.92e-06	0.00039	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AKT1—peripheral nervous system neoplasm	2.9e-06	0.000387	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	2.88e-06	0.000384	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	2.73e-06	0.000365	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	2.71e-06	0.000362	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	2.67e-06	0.000356	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	2.66e-06	0.000355	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.6e-06	0.000348	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	2.57e-06	0.000343	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.56e-06	0.000342	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.54e-06	0.00034	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.52e-06	0.000336	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.51e-06	0.000336	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.51e-06	0.000336	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	2.51e-06	0.000335	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	2.49e-06	0.000333	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.4e-06	0.00032	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.38e-06	0.000317	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.36e-06	0.000316	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	2.35e-06	0.000314	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.34e-06	0.000313	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.33e-06	0.000311	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	2.3e-06	0.000308	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.29e-06	0.000306	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	2.13e-06	0.000284	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	2.1e-06	0.00028	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	2.06e-06	0.000275	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.05e-06	0.000273	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.03e-06	0.000271	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	2e-06	0.000267	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.94e-06	0.00026	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.93e-06	0.000258	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.91e-06	0.000255	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.89e-06	0.000253	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.88e-06	0.000251	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.81e-06	0.000241	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.7e-06	0.000228	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.66e-06	0.000221	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.64e-06	0.000219	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.64e-06	0.000219	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.63e-06	0.000218	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.6e-06	0.000214	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.57e-06	0.000209	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.54e-06	0.000206	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.5e-06	0.000201	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.37e-06	0.000184	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.28e-06	0.000171	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.26e-06	0.000168	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.24e-06	0.000165	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.05e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	1.01e-06	0.000135	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.01e-06	0.000134	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	9.28e-07	0.000124	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.88e-07	0.000119	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	7.32e-07	9.78e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.91e-07	9.24e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	6.34e-07	8.47e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	5.66e-07	7.56e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	5.52e-07	7.38e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	5.2e-07	6.95e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	5.16e-07	6.89e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	4.41e-07	5.89e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.4e-07	4.55e-05	CbGpPWpGaD
